Annual D&A
$11.89 M
+$6.08 M+104.54%
31 December 2023
Summary:
Cytokinetics Incorporated annual depreciation & amortization is currently $11.89 million, with the most recent change of +$6.08 million (+104.54%) on 31 December 2023. During the last 3 years, it has risen by +$10.06 million (+549.48%). CYTK annual D&A is now at all-time high.CYTK Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.41 M
+$5000.00+0.21%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly depreciation & amortization is currently $2.41 million, with the most recent change of +$5000.00 (+0.21%) on 30 September 2024. Over the past year, it has increased by +$557.00 thousand (+30.04%). CYTK quarterly D&A is now -61.94% below its all-time high of $6.33 million, reached on 31 December 2023.CYTK Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$13.48 M
+$557.00 K+4.31%
30 September 2024
Summary:
Cytokinetics Incorporated TTM depreciation & amortization is currently $13.48 million, with the most recent change of +$557.00 thousand (+4.31%) on 30 September 2024. Over the past year, it has increased by +$6.27 million (+86.87%). CYTK TTM D&A is now at all-time high.CYTK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +104.5% | +30.0% | +86.9% |
| 3 y3 years | +549.5% | +421.9% | +569.8% |
| 5 y5 years | +859.8% | +617.6% | +2216.7% |
CYTK Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +549.5% | -61.9% | +421.9% | at high | +569.8% |
| 5 y | 5 years | at high | +859.8% | -61.9% | +617.6% | at high | +2216.7% |
| alltime | all time | at high | +2646.4% | -61.9% | +853.4% | at high | +3156.8% |
Cytokinetics Incorporated Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.41 M(+0.2%) | $13.48 M(+4.3%) |
| June 2024 | - | $2.41 M(+3.2%) | $12.93 M(+4.5%) |
| Mar 2024 | - | $2.33 M(-63.2%) | $12.38 M(+4.1%) |
| Dec 2023 | $11.89 M(+104.5%) | $6.33 M(+241.7%) | $11.89 M(+64.8%) |
| Sept 2023 | - | $1.85 M(-0.1%) | $7.21 M(+6.6%) |
| June 2023 | - | $1.85 M(+0.4%) | $6.77 M(+7.1%) |
| Mar 2023 | - | $1.85 M(+11.5%) | $6.32 M(+8.7%) |
| Dec 2022 | $5.81 M(+155.4%) | $1.66 M(+17.8%) | $5.81 M(+18.9%) |
| Sept 2022 | - | $1.41 M(+0.1%) | $4.89 M(+24.0%) |
| June 2022 | - | $1.41 M(+4.9%) | $3.94 M(+28.1%) |
| Mar 2022 | - | $1.34 M(+82.7%) | $3.08 M(+35.3%) |
| Dec 2021 | $2.28 M(+24.3%) | $734.00 K(+58.9%) | $2.28 M(+13.1%) |
| Sept 2021 | - | $462.00 K(-14.9%) | $2.01 M(-3.5%) |
| June 2021 | - | $543.00 K(+1.1%) | $2.09 M(+6.5%) |
| Mar 2021 | - | $537.00 K(+14.0%) | $1.96 M(+7.0%) |
| Dec 2020 | $1.83 M(+41.6%) | $471.00 K(-12.1%) | $1.83 M(+4.6%) |
| Sept 2020 | - | $536.00 K(+28.8%) | $1.75 M(+12.9%) |
| June 2020 | - | $416.00 K(+2.0%) | $1.55 M(+9.6%) |
| Mar 2020 | - | $408.00 K(+4.3%) | $1.42 M(+9.4%) |
| Dec 2019 | $1.29 M(+4.4%) | $391.00 K(+16.4%) | $1.29 M(+122.2%) |
| Sept 2019 | - | $336.00 K(+20.0%) | $582.00 K(+13.2%) |
| June 2019 | - | $280.00 K(-2.1%) | $514.00 K(-39.7%) |
| Mar 2019 | - | $286.00 K(-189.4%) | $852.00 K(-31.2%) |
| Dec 2018 | $1.24 M(-35.5%) | -$320.00 K(-219.4%) | $1.24 M(-42.9%) |
| Sept 2018 | - | $268.00 K(-56.6%) | $2.17 M(-7.7%) |
| June 2018 | - | $618.00 K(-8.2%) | $2.35 M(+8.2%) |
| Mar 2018 | - | $673.00 K(+10.3%) | $2.17 M(+13.1%) |
| Dec 2017 | $1.92 M(+159.1%) | $610.00 K(+35.6%) | $1.92 M(+25.2%) |
| Sept 2017 | - | $450.00 K(+2.5%) | $1.53 M(+21.6%) |
| June 2017 | - | $439.00 K(+4.3%) | $1.26 M(+27.1%) |
| Mar 2017 | - | $421.00 K(+87.9%) | $992.00 K(+33.9%) |
| Dec 2016 | $741.00 K(+25.8%) | $224.00 K(+26.6%) | $741.00 K(+10.9%) |
| Sept 2016 | - | $177.00 K(+4.1%) | $668.00 K(+4.9%) |
| June 2016 | - | $170.00 K(0.0%) | $637.00 K(+3.7%) |
| Mar 2016 | - | $170.00 K(+12.6%) | $614.00 K(+4.2%) |
| Dec 2015 | $589.00 K(+20.2%) | $151.00 K(+3.4%) | $589.00 K(+2.4%) |
| Sept 2015 | - | $146.00 K(-0.7%) | $575.00 K(+3.6%) |
| June 2015 | - | $147.00 K(+1.4%) | $555.00 K(+4.7%) |
| Mar 2015 | - | $145.00 K(+5.8%) | $530.00 K(+8.2%) |
| Dec 2014 | $490.00 K | $137.00 K(+8.7%) | $490.00 K(+11.1%) |
| Sept 2014 | - | $126.00 K(+3.3%) | $441.00 K(+6.0%) |
| June 2014 | - | $122.00 K(+16.2%) | $416.00 K(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $105.00 K(+19.3%) | $414.00 K(-4.4%) |
| Dec 2013 | $433.00 K(-26.7%) | $88.00 K(-12.9%) | $433.00 K(-8.6%) |
| Sept 2013 | - | $101.00 K(-15.8%) | $474.00 K(-7.6%) |
| June 2013 | - | $120.00 K(-3.2%) | $513.00 K(-4.5%) |
| Mar 2013 | - | $124.00 K(-3.9%) | $537.00 K(-9.1%) |
| Dec 2012 | $591.00 K(-54.4%) | $129.00 K(-7.9%) | $591.00 K(-14.5%) |
| Sept 2012 | - | $140.00 K(-2.8%) | $691.00 K(-14.3%) |
| June 2012 | - | $144.00 K(-19.1%) | $806.00 K(-23.4%) |
| Mar 2012 | - | $178.00 K(-22.3%) | $1.05 M(-18.9%) |
| Dec 2011 | $1.30 M(-31.7%) | $229.00 K(-10.2%) | $1.30 M(-15.3%) |
| Sept 2011 | - | $255.00 K(-34.6%) | $1.53 M(-12.4%) |
| June 2011 | - | $390.00 K(-7.8%) | $1.75 M(-4.7%) |
| Mar 2011 | - | $423.00 K(-8.6%) | $1.83 M(-3.5%) |
| Dec 2010 | $1.90 M(-6.0%) | $463.00 K(-1.7%) | $1.90 M(-1.6%) |
| Sept 2010 | - | $471.00 K(-1.3%) | $1.93 M(-1.5%) |
| June 2010 | - | $477.00 K(-2.5%) | $1.96 M(-1.7%) |
| Mar 2010 | - | $489.00 K(-1.0%) | $2.00 M(-1.3%) |
| Dec 2009 | $2.02 M(-17.7%) | $494.00 K(-1.4%) | $2.02 M(-3.3%) |
| Sept 2009 | - | $501.00 K(-2.0%) | $2.09 M(-5.3%) |
| June 2009 | - | $511.00 K(-0.8%) | $2.21 M(-5.3%) |
| Mar 2009 | - | $515.00 K(-8.5%) | $2.33 M(-5.0%) |
| Dec 2008 | $2.46 M(-13.2%) | $563.00 K(-9.0%) | $2.46 M(-3.8%) |
| Sept 2008 | - | $619.00 K(-2.5%) | $2.55 M(-2.0%) |
| June 2008 | - | $635.00 K(-0.6%) | $2.60 M(-4.1%) |
| Mar 2008 | - | $639.00 K(-3.0%) | $2.71 M(-4.1%) |
| Dec 2007 | $2.83 M(-3.3%) | $659.00 K(-1.6%) | $2.83 M(-1.6%) |
| Sept 2007 | - | $670.00 K(-10.1%) | $2.88 M(-1.9%) |
| June 2007 | - | $745.00 K(-1.3%) | $2.93 M(+0.0%) |
| Mar 2007 | - | $755.00 K(+6.9%) | $2.93 M(+0.1%) |
| Dec 2006 | $2.93 M(-4.4%) | $706.00 K(-2.8%) | $2.93 M(-1.2%) |
| Sept 2006 | - | $726.00 K(-2.4%) | $2.96 M(-1.1%) |
| June 2006 | - | $744.00 K(-0.9%) | $3.00 M(-0.9%) |
| Mar 2006 | - | $751.00 K(+1.1%) | $3.02 M(-1.2%) |
| Dec 2005 | $3.06 M(-6.5%) | $743.00 K(-2.2%) | $3.06 M(-2.3%) |
| Sept 2005 | - | $760.00 K(-1.4%) | $3.13 M(-2.1%) |
| June 2005 | - | $771.00 K(-2.2%) | $3.20 M(-1.4%) |
| Mar 2005 | - | $788.00 K(-3.4%) | $3.25 M(-0.9%) |
| Dec 2004 | $3.28 M(+3.0%) | $816.00 K(-1.2%) | $3.28 M(+33.2%) |
| Sept 2004 | - | $826.00 K(+1.3%) | $2.46 M(+50.6%) |
| June 2004 | - | $815.00 K(-0.5%) | $1.63 M(+99.5%) |
| Mar 2004 | - | $819.00 K | $819.00 K |
| Dec 2003 | $3.18 M(+11.7%) | - | - |
| Dec 2002 | $2.85 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual D&A year-on-year change?
- What is Cytokinetics Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly D&A year-on-year change?
- What is Cytokinetics Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM D&A year-on-year change?
What is Cytokinetics Incorporated annual depreciation & amortization?
The current annual D&A of CYTK is $11.89 M
What is the all time high annual D&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual depreciation & amortization is $11.89 M
What is Cytokinetics Incorporated annual D&A year-on-year change?
Over the past year, CYTK annual depreciation & amortization has changed by +$6.08 M (+104.54%)
What is Cytokinetics Incorporated quarterly depreciation & amortization?
The current quarterly D&A of CYTK is $2.41 M
What is the all time high quarterly D&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly depreciation & amortization is $6.33 M
What is Cytokinetics Incorporated quarterly D&A year-on-year change?
Over the past year, CYTK quarterly depreciation & amortization has changed by +$557.00 K (+30.04%)
What is Cytokinetics Incorporated TTM depreciation & amortization?
The current TTM D&A of CYTK is $13.48 M
What is the all time high TTM D&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM depreciation & amortization is $13.48 M
What is Cytokinetics Incorporated TTM D&A year-on-year change?
Over the past year, CYTK TTM depreciation & amortization has changed by +$6.27 M (+86.87%)